| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |